Payment overview · 2025
General Payments
$50.01
2 reported records · 2 companies
Healthcare provider profile · identity verified
Thaw Tun, MD
Allopathic & Osteopathic Physicians|Internal Medicine · HENRY, IL · NPI 1326142902
Verified facts
What the public records show
CMS Open Payments records show Thaw Tun, MD received $50.01 in general payments during 2025 across 2 reported records.
Novartis Pharmaceuticals Corporation accounted for 63.8% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $31.92 | 63.8% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $18.09 | 36.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $50.01 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $31.92 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $18.09 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 780 | 228 |
| Levothyroxine Sodium | Levothyroxine Sodium | 660 | 200 |
| Pantoprazole Sodium | Pantoprazole Sodium | 623 | 180 |
| Metformin Hcl Er | Metformin Hcl | 498 | 152 |
| Lisinopril | Lisinopril | 404 | 121 |
| Metoprolol Succinate | Metoprolol Succinate | 396 | 115 |
| Atorvastatin Calcium | Atorvastatin Calcium | 328 | 113 |
| Amlodipine Besylate | Amlodipine Besylate | 317 | 105 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 315 | 61 |
| Losartan Potassium | Losartan Potassium | 306 | 94 |
| Tramadol Hcl | Tramadol Hcl | 283 | 79 |
| Eliquis | Apixaban | 263 | 56 |
| Omeprazole | Omeprazole | 248 | 83 |
| Alprazolam | Alprazolam | 233 | 60 |
| Gabapentin | Gabapentin | 195 | 66 |
| Pravastatin Sodium | Pravastatin Sodium | 194 | 62 |
| Meloxicam | Meloxicam | 189 | 58 |
| Metoprolol Tartrate | Metoprolol Tartrate | 188 | 50 |
| Simvastatin | Simvastatin | 178 | 59 |
| Lorazepam | Lorazepam | 177 | 49 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 174 | 50 |
| Furosemide | Furosemide | 166 | 57 |
| Potassium Chloride | Potassium Chloride | 165 | 54 |
| Carvedilol | Carvedilol | 160 | 40 |
| Diclofenac Sodium | Diclofenac Sodium | 149 | 47 |
| Amitriptyline Hcl | Amitriptyline Hcl | 129 | 34 |
| Tamsulosin Hcl | Tamsulosin Hcl | 129 | 39 |
| Allopurinol | Allopurinol | 126 | 42 |
| Fluticasone Propionate | Fluticasone Propionate | 125 | 40 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 123 | 38 |
| Pregabalin | Pregabalin | 117 | 21 |
| Jardiance | Empagliflozin | 110 | 35 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 108 | 29 |
| Warfarin Sodium | Warfarin Sodium | 105 | 27 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 100 | 28 |
| Azithromycin | Azithromycin | 94 | 75 |
| Escitalopram Oxalate | Escitalopram Oxalate | 94 | 27 |
| Metformin Hcl | Metformin Hcl | 94 | 52 |
| Methylprednisolone | Methylprednisolone | 94 | 65 |
| Clopidogrel | Clopidogrel Bisulfate | 91 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 91 | 33 |
| Spironolactone | Spironolactone | 90 | 30 |
| Telmisartan | Telmisartan | 88 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 85 | 24 |
| Memantine Hcl | Memantine Hcl | 80 | 25 |
| Clonazepam | Clonazepam | 71 | 12 |
| Minoxidil | Minoxidil | 70 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 69 | 31 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 64 | 35 |
| Januvia | Sitagliptin Phosphate | 64 | 16 |
| Synthroid | Levothyroxine Sodium | 64 | 17 |
| Ezetimibe | Ezetimibe | 60 | 21 |
| Atenolol | Atenolol | 59 | 17 |
| Prednisone | Prednisone | 59 | 22 |
| Tresiba Flextouch U-200 | Insulin Degludec | 59 | 11 |
| Montelukast Sodium | Montelukast Sodium | 58 | 19 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 57 | 17 |
| Levofloxacin | Levofloxacin | 54 | 43 |
| Duloxetine Hcl | Duloxetine Hcl | 53 | 16 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 50 | 31 |
| Xarelto | Rivaroxaban | 49 | 11 |
| Farxiga | Dapagliflozin Propanediol | 47 | 13 |
| Sertraline Hcl | Sertraline Hcl | 46 | 18 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 44 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 43 | 40 |
| Baclofen | Baclofen | 41 | suppressed |
| Lactulose | Lactulose | 36 | 14 |
| Ondansetron Odt | Ondansetron | 36 | 14 |
| Diazepam | Diazepam | 35 | suppressed |
| Estradiol | Estradiol | 35 | 12 |
| Irbesartan | Irbesartan | 35 | 13 |
| Lovastatin | Lovastatin | 35 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 34 | 15 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 34 | 26 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 33 | suppressed |
| Topiramate | Topiramate | 33 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 32 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 32 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | suppressed |
| Glimepiride | Glimepiride | 30 | 12 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 30 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 30 | 13 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 30 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 29 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 29 | suppressed |
| Mirtazapine | Mirtazapine | 29 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 29 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 29 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 29 | suppressed |
| Ramipril | Ramipril | 29 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 28 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 28 | 18 |
| Pentoxifylline | Pentoxifylline | 27 | suppressed |
| Sucralfate | Sucralfate | 27 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 26 | suppressed |
| Bupropion Xl | Bupropion Hcl | 25 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 25 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 25 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 25 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 24 | suppressed |
| Ozempic | Semaglutide | 24 | suppressed |
| Fenofibrate | Fenofibrate | 23 | suppressed |
| Fentanyl | Fentanyl | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | suppressed |
| Celecoxib | Celecoxib | 22 | suppressed |
| Methotrexate | Methotrexate Sodium | 22 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 21 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 21 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 20 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 19 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 19 | 14 |
| Clonidine Hcl | Clonidine Hcl | 19 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 19 | suppressed |
| Cilostazol | Cilostazol | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 17 | suppressed |
| Klor-Con M20 | Potassium Chloride | 17 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 16 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 11 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 16 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 16 | suppressed |
| Repatha Sureclick | Evolocumab | 16 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 15 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Nitroglycerin | Nitroglycerin | 15 | 14 |
| Primidone | Primidone | 15 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 15 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 15 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 14 | suppressed |
| Trazodone Hcl | Trazodone Hcl | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | 11 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 13 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Aimovig Autoinjector | Erenumab-Aooe | 12 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Fingolimod | Fingolimod Hcl | 12 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 12 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 12 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 12 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Anastrozole | Anastrozole | 11 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Lamotrigine | Lamotrigine | 11 | suppressed |
| Levetiracetam | Levetiracetam | 11 | suppressed |
| Rybelsus | Semaglutide | 11 | suppressed |
| Tradjenta | Linagliptin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $50.01 · 2 records | Novartis Pharmaceuticals Corporation | EVENITY, LEQVIO | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error